Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ovotransferrin in COVID-19 Patients With Mild-to-Moderate Disease

NCT04643054 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo as lead sponsor.

NCT NCT04643054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ovotransferrin in COVID-19 Patients With Mild-to-Moderate Disease
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2020
Completion date
March 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19